| abstract |
The application describes a compound of the formula which is 4-hydroxy-4-methylpiperidin-1-carboxylic acid (4-methoxy-7-morpholin-4-ylbenzothiazol-2-yl) -amide, and its pharmaceutically acceptable molecular salts with acids. This compound has been found to be useful in treating or preventing Alzheimer's disease, Parkinson’s disease, Huntington’s disease, providing neuroprotection, schizophrenia, anxiety, pain, respiratory distress, depression, ADHD (attention deficit hyperactivity disorder), drug abuse with amphetamines, cocaine, opioids, ethanol, nicotine, cannabioids, or for the treatment of asthma, allergic reactions, hypoxia, ischemia, seizure, substance abuse, or for use as muscle relaxants, antipsychotics, antiepilepses ttic, anticonvulsant and cardioprotective agents. |